These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges. Falabella M; Minczuk M; Hanna MG; Viscomi C; Pitceathly RDS Nat Rev Neurol; 2022 Nov; 18(11):689-698. PubMed ID: 36257993 [TBL] [Abstract][Full Text] [Related]
24. Hereditary Optic Neuropathies: A Systematic Review on the Interplay between Biomaterials and Induced Pluripotent Stem Cells. Ladero M; Reche-Sainz JA; Gallardo ME Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247929 [TBL] [Abstract][Full Text] [Related]
25. Chronic Glaucoma Induced in Rats by a Single Injection of Fibronectin-Loaded PLGA Microspheres: IOP-Dependent and IOP-Independent Neurodegeneration. Munuera I; Aragon-Navas A; Villacampa P; Gonzalez-Cela MA; Subías M; Pablo LE; Garcia-Feijoo J; Herrero-Vanrell R; Garcia-Martin E; Bravo-Osuna I; Rodrigo MJ Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203183 [TBL] [Abstract][Full Text] [Related]
26. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs. Kontoghiorghes GJ Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069073 [TBL] [Abstract][Full Text] [Related]
27. Optimized allotopic expression of mitochondrial ND6 transgene restored complex I and apoptosis deficiencies caused by LHON-linked ND6 14484T > C mutation. Wang J; Ji Y; Ai C; Chen JR; Gan D; Zhang J; Mo JQ; Guan MX J Biomed Sci; 2023 Aug; 30(1):63. PubMed ID: 37537557 [TBL] [Abstract][Full Text] [Related]
30. Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation. Mashima Y; Kigasawa K; Shinoda K; Wakakura M; Oguchi Y BMC Ophthalmol; 2017 Oct; 17(1):192. PubMed ID: 29047345 [TBL] [Abstract][Full Text] [Related]
31. Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset. Pemp B; Kircher K; Reitner A Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2751-2757. PubMed ID: 31482278 [TBL] [Abstract][Full Text] [Related]
32. Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy. Shamsnajafabadi H; MacLaren RE; Cehajic-Kapetanovic J Cells; 2023 Aug; 12(15):. PubMed ID: 37566092 [TBL] [Abstract][Full Text] [Related]
33. Leber hereditary optic neuropathy: new and emerging therapies. Davila-Siliezar P; Carter M; Milea D; Lee AG Curr Opin Ophthalmol; 2022 Nov; 33(6):574-578. PubMed ID: 36066375 [TBL] [Abstract][Full Text] [Related]